Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 3Glioblastoma 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Osteonecrosis 1Osteomyelitis 1Neurodegenerative Diseases 1Malignant Solid Neoplasm 1Kidney Neoplasms 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Head and Neck Neoplasms 1Glioma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Childhood Brain Neoplasm 1Central Nervous System Vascular Malformations 1Central Nervous System Infections 1Carcinoma, Medullary 1Cancer of Lymph Node 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4pimonidazole 2TH 302 2gadobutrol 1fluoromisonidazole 1Surgical Procedures, Operative 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Radiotherapy 1Propofol 1Positron Emission Tomography Computed Tomography 1Pancreaticoduodenectomy 1Oxygen 1NVP-BKM120 1Ketamine 1Gemcitabine 1Ferrosoferric Oxide 1Dexmedetomidine 1Blood Specimen Collection 1Biopsy 1Bacterial Load 1Atovaquone 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypoxia × Ferrosoferric Oxide × Clear all
NCT02466828 2018-04-18

qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.

Sunnybrook Health Sciences Centre

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Hypoxia, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡